Dimensional Fund Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.5M | Buy |
960,056
+207,913
| +28% | +$2.6M | ﹤0.01% | 2244 |
|
|
2025
Q4 | $9.73M | Buy |
752,143
+186,380
| +33% | +$2.39M | ﹤0.01% | 2294 |
|
|
2025
Q3 | $7.31M | Buy |
565,763
+539,609
| +2,063% | +$7.21M | ﹤0.01% | 2413 |
|
|
2025
Q2 | $466K | Buy |
26,154
+847
| +3% | +$14.8K | ﹤0.01% | 3006 |
|
|
2025
Q1 | $452K | Sell |
25,307
-446
| -2% | -$10.1K | ﹤0.01% | 3016 |
|
|
2024
Q4 | $768K | Sell |
25,753
-3,016
| -10% | -$63.8K | ﹤0.01% | 2961 |
|
|
2024
Q3 | $450K | Sell |
28,769
-895
| -3% | -$16.2K | ﹤0.01% | 3057 |
|
|
2024
Q2 | $509K | Sell |
29,664
-785
| -3% | -$13.8K | ﹤0.01% | 3024 |
|
|
2024
Q1 | $476K | Sell |
30,449
-6,762
| -18% | -$99.4K | ﹤0.01% | 3052 |
|
|
2023
Q4 | $557K | Buy |
37,211
+2,439
| +7% | +$32.6K | ﹤0.01% | 3024 |
|
|
2023
Q3 | $562K | Sell |
34,772
-67,795
| -66% | -$1.95M | ﹤0.01% | 3029 |
|
|
2023
Q2 | $4.26M | Sell |
102,567
-75,264
| -42% | -$4.67M | ﹤0.01% | 2588 |
|
|
2023
Q1 | $10.7M | Buy |
177,831
+12,948
| +8% | +$1.03M | ﹤0.01% | 2204 |
|
|
2022
Q4 | $12.1K | Buy |
164,883
+2,543
| +2% | +$191K | ﹤0.01% | 2112 |
|
|
2022
Q3 | $12.3M | Buy |
162,340
+18,148
| +13% | +$1.42M | ﹤0.01% | 2075 |
|
|
2022
Q2 | $10M | Buy |
144,192
+16,759
| +13% | +$1.26M | ﹤0.01% | 2191 |
|
|
2022
Q1 | $10.6M | Buy |
127,433
+2,534
| +2% | +$187K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $9.38M | Buy |
124,899
+2,760
| +2% | +$277K | ﹤0.01% | 2335 |
|
|
2021
Q3 | $14.2M | Sell |
122,139
-1,003
| -0.8% | -$152K | ﹤0.01% | 2169 |
|
|
2021
Q2 | $27.3M | Sell |
123,142
-37,052
| -23% | -$7.21M | 0.01% | 1903 |
|
|
2021
Q1 | $21.2M | Sell |
160,194
-4,120
| -3% | -$652K | 0.01% | 2005 |
|
|
2020
Q4 | $28.4M | Buy |
164,314
+6,883
| +4% | +$942K | 0.01% | 1791 |
|
|
2020
Q3 | $17.5M | Buy |
157,431
+7,232
| +5% | +$578K | 0.01% | 1919 |
|
|
2020
Q2 | $8.9M | Buy |
150,199
+1,574
| +1% | +$104K | ﹤0.01% | 2247 |
|
|
2020
Q1 | $10M | Sell |
148,625
-6,013
| -4% | -$475K | 0.01% | 2118 |
|
|
2019
Q4 | $13M | Buy |
154,638
+15,198
| +11% | +$1.23M | ﹤0.01% | 2248 |
|
|
2019
Q3 | $10.4M | Buy |
139,440
+41,164
| +42% | +$3.29M | ﹤0.01% | 2325 |
|
|
2019
Q2 | $6.21M | Sell |
98,276
-45,350
| -32% | -$2.3M | ﹤0.01% | 2576 |
|
|
2019
Q1 | $6.92M | Buy |
+143,626
| New | +$6.91M | ﹤0.01% | 2536 |
|
|
2018
Q4 | – | Sell |
-25,242
| Closed | -$1.32M | – | 3457 |
|
|
2018
Q3 | $1.32M | Buy |
+25,242
| New | +$1M | ﹤0.01% | 3009 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM
Dimensional Fund Advisors's NVCR Position: Q1 2026 in Review
Dimensional Fund Advisors increased its NovoCure (NVCR) stake by 28% in Q1 2026, buying an estimated $2.6M and bringing the position to 960,056 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2244.
Dimensional Fund Advisors first reported a position in NVCR in Q3 2018 and has held it in 30 quarters since. The position peaked at $28.4M in Q4 2020. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- Dimensional Fund Advisors held 960,056 shares of NovoCure worth $10.5M as of Q1 2026.
- Dimensional Fund Advisors bought 207,913 NovoCure shares in Q1 2026, an estimated $2.6M.
- NovoCure made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2244 holding.
- Dimensional Fund Advisors first reported a position in NovoCure in Q3 2018 and has held it in 30 quarters since.
- Dimensional Fund Advisors's NovoCure position peaked at $28.4M in Q4 2020.
- 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.